WCLC 2023 | Unmet needs in limited-stage small cell lung carcinoma

Bjørn Henning Grønberg, MD PhD, Norwegian University of Science and Technology, Trondheim, Norway, shares the unmet needs in limited-stage small lung cell cancer (LS-SCLC) and potential strategies to accommodate these requirements. As the majority of SCLC patients experience relapse and effective treatments are still lacking, current trials aim to investigate radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.